EFSD/MSD European Research Program on Novel Therapies for Type-2 Diabetes |
The European Foundation for the Study of Diabetes (EFSD) and Merck Sharp Dohme (MSD) have established a European Research Programme for preclinical/translational research on novel therapies to encourage the identification of new targets for the treatment of type 2 diabetes.
Requirements
Applications for an EFSD New Targets grant are invited from single non-profit institutions or groups of such institutions from Europe and associated countries. The principal investigator and any co-investigators must be employed full-time at a non-profit institution and the study must be performed at their place of work.
Research areas
Proposals may include but are not limited to
- Mechanisms to induce “browning of adipose tissue”
- New targets for improving skeletal muscle or adipose tissue insulin resistance
- Bile acid biology as it relates to metabolic disease. This includes actions relating to glucose metabolism, lipid metabolism, energy balance and related diseases including diabetes, atherosclerosis and obesity
- Lipid metabolism as it relates to insulin action
- Mechanisms of glucose-dependent insulin and glucagon secretion
Review criteria
- Significance: Does the study address an important problem in keeping with the goals and focus areas of this Programme? If the aims of the application are achieved, how will scientific knowledge be advanced? What will be the effect of the proposed studies on the concepts or methods that drive this field?
- Approach: Are the conceptual framework, design, methods and analyses adequately developed, well integrated, and appropriate to the aims of the project? Are they supported by preliminary data? Does the applicant acknowledge potential problem areas and consider alternative tactics?
- Innovation: Does the project employ novel concepts, approaches or methods? Are the aims original and innovative? Does the project challenge existing paradigms or develop new methodologies or technologies?
- Investigator: Is the investigator appropriately trained and well suited to carry out this work? Is the work proposed appropriate to the experience level of the principal investigator and other researchers, if any?
- Environment: Does the scientific environment in which the work will be done contribute to the probability of success? Do the proposed studies take advantage of unique features of the scientific environment or employ useful collaborative arrangements? Is there evidence of institutional support?
- Budget and feasibility: Is the requested budget appropriate for the proposed study? Is the requested duration suitable for completion of the project?
- Contribution towards a larger research project: Is the work described in the application intended as part of a larger project? If so, is there any overlap? Is there a clear explanation how the new work will contribute towards the overall success of that larger project?
Amount and duration
Research will be supported through the award of grants, each of up to 100,000 €, payable in the first year and in one instalment. The duration of each award may be 1 year or longer, depending upon the needs of the project and as justified in the application.
Deadlines
- VHIR deadline: 8 June 2015
- Official deadline: 15 June 2015 (12h CET) to Foundation@easd.org
- Anticipated award: October 2015
More information: HERE
© FIR-HUVH Fundació Institut de Recerca Hospital Universitari Vall d'Hebron 2014 | Vull rebre informació del VHIR ![]() |
Ajudi’ns a millorar ![]() |
![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |